YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
1 Healthcare Stock with Exciting Potential and 2 We Find Risky Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as healthcare stocks…
Lantheus Holdings, Inc. Designation, together with a permanent HCPCS code effective October 1, 2026, supports patient access and reimbursement for PYLARIFY TruVu, Lantheus' PSMA PET imaging agent BEDFORD, Mass., Sept. 30, 2026 (GLOBE NEWSW…
Healthcare Equipment and Supplies Stocks Q2 Highlights: GE HealthCare (NASDAQ:GEHC) Quarterly earnings results are a good time to check in on a company's progress, especially compared to its peers in the same sector. Today we are looking a…
Lantheus Holdings, Inc. Study advances development of Lantheus' investigational GRPR-targeted PET imaging program for prostate cancer BEDFORD, Mass., Sept. 28, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. ("Lantheus" or the "Company")…
FDA approval for BRAVNETSA puts Lantheus Holdings (LNTH) in focus Lantheus Holdings (LNTH) drew fresh attention after the FDA granted final approval for BRAVNETSA, a radiopharmaceutical considered bioequivalent and therapeutically equivale…
Lantheus Holdings has delivered a powerful 5 year share price run, and the recent pullback leaves investors asking whether the current US$99.74 level is still grounded in the cash the business can generate. With fresh product news in its c…
Polaris Capital Management, an investment management company, released its second-quarter 2026 investor letter for "Global Equity Strategy". The letter can be downloaded here. Global markets delivered strong gains during the quarter, suppo…
3 Reasons LNTH is Risky and 1 Stock to Buy Instead Lantheus currently trades at $100.02 and has been a dream stock for shareholders. It's returned 270% since September 2021, blowing past the S&P 500's 74.5% gain. The company has also beate…
Lantheus Holdings, Inc. Approval of BRAVNETSA expands radioligand treatment options for adult patients with somatostatin receptor-positive (SSTR+) gastroenteropancreatic neuroendocrine tumors (GEP-NETs) BEDFORD, Mass., Sept. 22, 2026 (GLOB…
* Lantheus Holdings (LNTH [https://seekingalpha.com/symbol/LNTH]) said it has withdrawn and refiled its Hart-Scott-Rodino (HSR) Act pre-merger notification regarding its $8B acquisition [https://seekingalpha.com/news/4623348-curium-to-buy-…
2 Small-Cap Stocks to Consider Right Now and 1 That Underwhelm Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses ha…
Healthcare Equipment and Supplies Stocks Q2 Recap: Benchmarking Lantheus (NASDAQ:LNTH) As the Q2 earnings season comes to a close, it's time to take stock of this quarter's best and worst performers in the healthcare equipment and supplies…
[US Food and Drug Administration (FDA)] Lantheus Holdings (LNTH [https://seekingalpha.com/symbol/LNTH]) on Friday announced the FDA approval of Tauklarify, a radiodiagnostic agent designed to identify tau pathology of the brain in adults w…
Lantheus Holdings, Inc. BEDFORD, Mass., Aug. 14, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight…
Here's a list of key deals reported across sectors this week: DoubleVerify (DV [https://seekingalpha.com/symbol/DV]) agreed to be acquired [https://seekingalpha.com/pr/20611211-nielsen-to-acquire-doubleverify-creating-a-leading-independent…
Lantheus (NASDAQ:LNTH) Reports Upbeat Q2 CY2026 Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) reported revenue ahead of Wall Street's expectations in Q2 CY2026, with sales up 2.7% year on year to $388.2 million. Its non-GAAP…
Lantheus Holdings, Inc. Worldwide revenue of $388.2 million in the second quarter of 2026 GAAP fully diluted earnings per share of $1.11, compared to $1.12 in the second quarter of 2025 Adjusted fully diluted earnings per share of $1.55, c…
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. Shareholders are encouraged to contact the firm to…
CapVest Partners-backed Curium has agreed to buy rival US-based radiopharmaceutical company Lantheus in an all-cash deal worth up to nearly $8bn. The deal will take the Nasdaq-listed Lantheus private. Under the agreement, Curium US will pu…
1 Healthcare Stock Worth Your Attention and 2 We Question From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have not only realized strong finan…
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Curium has entered into a definitive agreement to acquire Lantheus Holdings (NasdaqGM:LNTH) in a tr…
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. Shareholders are encouraged to contact the firm to…
(Updates with latest market prices and developments.) US stocks climbed intraday as oil prices fe PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news…
All three major US stock indexes were up in late-morning trading Monday after President Donald Trump PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
By Kamal Choudhury and Kunal Das Aug 3 (Reuters) - Radiopharmaceutical company Curium has agreed to buy peer Lantheus Holdings in a deal worth up to $8 billion, as the private equity-backed firm looks to expand its footprint in the fast-…
Lantheus (LNTH) has agreed to be acquired and taken private by Curium in an up to $8 billion deal th PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
Curium Strategic transaction would bring Curium's theranostics portfolio and global manufacturing platform together with Lantheus' complementary U.S. radiodiagnostics business Total transaction consideration to Lantheus shareholders of up…
[Business mergers and acquisitions concept. Share acquisition, asset business acquisition, amalgamation. Business review and development model. The abbreviation M and A on smart background, copy space.] Parradee Kietsirikul Here's a list o…
Wall Street's major market averages finished higher on Friday in a choppy session that saw Amazon shares climb on strong quarterly results. The blue-chip Dow rose 0.5%, the benchmark S&P 500 gained 0.7%, and the tech-focused Nasdaq Composi…
(RTTNews) - As we head into August, it's time for our monthly roundup of the upcoming FDA decisions that could move biotech stocks. The August regulatory calendar spans a wide range of indications - from the ultra-rare Fibrodysplasia Ossif…
If you're interested in broad exposure to the Mid Cap Blend segment of the US equity market, look no further than the Invesco S&P MidCap 400 GARP ETF (GRPM), a passively managed exchange traded fund launched on December 3, 2010. The fund i…
Lantheus Holdings, Inc. BEDFORD, Mass., July 23, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the "Company") (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Thursday, August 6, 2026, t…
Designed to provide broad exposure to the Style Box - Mid Cap Blend category of the market, the Invesco S&P MidCap 400 GARP ETF (GRPM) is a smart beta exchange traded fund launched on 12/03/2010. What Are Smart Beta ETFs? Market cap weight…
1 Unpopular Stock That Deserves a Second Chance and 2 We Ignore When Wall Street turns bearish on a stock, it's worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will…
RadioMedix, Inc. Leading pharmaceutical executive brings over 4 decades of commercial, M&A, and governance leadership HOUSTON, July 15, 2026 (GLOBE NEWSWIRE) -- RadioMedix, Inc., a clinical-stage biotechnology company focused on innovative…
3 Reasons to Avoid LNTH and 1 Stock to Buy Instead What a fantastic six months it's been for Lantheus. Shares of the company have skyrocketed 60.5%, hitting $105.30. This was partly thanks to its solid quarterly results, and the performanc…